Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 51

1.

Dacryostenosis due to Paracoccidioides brasiliensis in a patient with an unnoted HIV-1 infection.

Almeida RA, Narikawa S, Tagliarini JV, Marques ME, Schellini SA.

Can J Ophthalmol. 2013 Aug;48(4):e61-2. doi: 10.1016/j.jcjo.2013.01.011. No abstract available.

PMID:
23931481
2.

[Eyelid tumor in anophthalmic socket due to retinoblastoma: report of two cases].

Narikawa S, Marques ME, Schellini SA.

Arq Bras Oftalmol. 2011 Sep-Oct;74(5):365-7. Portuguese.

3.

[Profile of patients with anophthalmic cavity: study at Faculdade de Medicina de Botucatu - UNESP].

Narikawa S, Natsuaki KL, Fruet J, Padovani CR, Schellini SA.

Arq Bras Oftalmol. 2011 Sep-Oct;74(5):357-60. Portuguese.

4.

[Frequency of occurrence of eyelid basal cell carcinoma in the centralwest region of São Paulo State and carriers characteristics].

Narikawa S, Padovani CR, Schellini SA.

Arq Bras Oftalmol. 2011 Jul-Aug;74(4):245-7. Portuguese.

5.
6.

[Eyelid ectropium prevalence and carriers characteristics in a population from the Center-Western region of São Paulo State].

Silva Cdo P, Schellini SA, Padovani CR, Narikawa S.

Arq Bras Oftalmol. 2009 Jan-Feb;72(1):39-42. Portuguese.

7.
8.

Restoration of visual response in aged dystrophic RCS rats using AAV-mediated channelopsin-2 gene transfer.

Tomita H, Sugano E, Yawo H, Ishizuka T, Isago H, Narikawa S, Kügler S, Tamai M.

Invest Ophthalmol Vis Sci. 2007 Aug;48(8):3821-6.

PMID:
17652757
9.

[Eyelash alterations in anophthalmic patients].

Narikawa S, Schellini SA, Padovani CR, Padovani CR.

Arq Bras Oftalmol. 2007 Jan-Feb;70(1):51-4. Portuguese.

10.

Cyclic AMP-dependent memory mutants are defective in the food choice behavior of Drosophila.

Motosaka K, Koganezawa M, Narikawa S, Furuyama A, Shinozaki K, Isono K, Shimada I.

J Comp Physiol A Neuroethol Sens Neural Behav Physiol. 2007 Feb;193(2):279-83. Epub 2006 Dec 19.

PMID:
17180701
11.

[Myocardial remodeling in chronic pressure or volume overload in the rat heart].

Matsubara LS, Narikawa S, Ferreira AL, Paiva SA, Zornoff LM, Matsubara BB.

Arq Bras Cardiol. 2006 Feb;86(2):126-30. Epub 2006 Feb 20. Portuguese.

12.

[Congenital lacrimal obstruction: outcome and factors associated with therapeutic probing].

Schellini SA, Narikawa S, Ribeiro SC, Nakagima V, Padovani CR, Padovani CR.

Arq Bras Oftalmol. 2005 Sep-Oct;68(5):627-30. Epub 2005 Nov 28. Portuguese.

13.

Characterization of the renal tubular transport of zonampanel, a novel alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor antagonist, by human organic anion transporters.

Hashimoto T, Narikawa S, Huang XL, Minematsu T, Usui T, Kamimura H, Endou H.

Drug Metab Dispos. 2004 Oct;32(10):1096-102.

PMID:
15377641
14.

Human organic cation transporter 3 mediates the transport of antiarrhythmic drugs.

Hasannejad H, Takeda M, Narikawa S, Huang XL, Enomoto A, Taki K, Niwa T, Jung SH, Onozato ML, Tojo A, Endou H.

Eur J Pharmacol. 2004 Sep 19;499(1-2):45-51.

PMID:
15363950
15.

Interactions of human- and rat-organic anion transporters with pravastatin and cimetidine.

Khamdang S, Takeda M, Shimoda M, Noshiro R, Narikawa S, Huang XL, Enomoto A, Piyachaturawat P, Endou H.

J Pharmacol Sci. 2004 Feb;94(2):197-202.

16.

Expression of human organic anion transporters in the choroid plexus and their interactions with neurotransmitter metabolites.

Alebouyeh M, Takeda M, Onozato ML, Tojo A, Noshiro R, Hasannejad H, Inatomi J, Narikawa S, Huang XL, Khamdang S, Anzai N, Endou H.

J Pharmacol Sci. 2003 Dec;93(4):430-6.

17.

Evidence for a role of human organic anion transporters in the muscular side effects of HMG-CoA reductase inhibitors.

Takeda M, Noshiro R, Onozato ML, Tojo A, Hasannejad H, Huang XL, Narikawa S, Endou H.

Eur J Pharmacol. 2004 Jan 12;483(2-3):133-8.

PMID:
14729100
18.

Interactions of human organic anion transporters with diuretics.

Hasannejad H, Takeda M, Taki K, Shin HJ, Babu E, Jutabha P, Khamdang S, Aleboyeh M, Onozato ML, Tojo A, Enomoto A, Anzai N, Narikawa S, Huang XL, Niwa T, Endou H.

J Pharmacol Exp Ther. 2004 Mar;308(3):1021-9. Epub 2003 Nov 10.

PMID:
14610216
19.

Interaction of human and rat organic anion transporter 2 with various cephalosporin antibiotics.

Khamdang S, Takeda M, Babu E, Noshiro R, Onozato ML, Tojo A, Enomoto A, Huang XL, Narikawa S, Anzai N, Piyachaturawat P, Endou H.

Eur J Pharmacol. 2003 Mar 28;465(1-2):1-7.

PMID:
12650826
20.

Interactions of human organic anion transporters and human organic cation transporters with nonsteroidal anti-inflammatory drugs.

Khamdang S, Takeda M, Noshiro R, Narikawa S, Enomoto A, Anzai N, Piyachaturawat P, Endou H.

J Pharmacol Exp Ther. 2002 Nov;303(2):534-9.

PMID:
12388633
21.

Characterization of methotrexate transport and its drug interactions with human organic anion transporters.

Takeda M, Khamdang S, Narikawa S, Kimura H, Hosoyamada M, Cha SH, Sekine T, Endou H.

J Pharmacol Exp Ther. 2002 Aug;302(2):666-71.

PMID:
12130730
22.

Role of human organic anion transporter 4 in the transport of ochratoxin A.

Babu E, Takeda M, Narikawa S, Kobayashi Y, Enomoto A, Tojo A, Cha SH, Sekine T, Sakthisekaran D, Endou H.

Biochim Biophys Acta. 2002 Jun 12;1590(1-3):64-75.

23.

Interaction of human organic anion transporters 2 and 4 with organic anion transport inhibitors.

Enomoto A, Takeda M, Shimoda M, Narikawa S, Kobayashi Y, Kobayashi Y, Yamamoto T, Sekine T, Cha SH, Niwa T, Endou H.

J Pharmacol Exp Ther. 2002 Jun;301(3):797-802.

PMID:
12023506
24.

Involvement of rat organic anion transporter 3 (rOAT3) in cephaloridine-induced nephrotoxicity: in comparison with rOAT1.

Jung KY, Takeda M, Shimoda M, Narikawa S, Tojo A, Kim DK, Chairoungdua A, Choi BK, Kusuhara H, Sugiyama Y, Sekine T, Endou H.

Life Sci. 2002 Mar 8;70(16):1861-74.

PMID:
12005172
25.

Interaction of human organic anion transporters with various cephalosporin antibiotics.

Takeda M, Babu E, Narikawa S, Endou H.

Eur J Pharmacol. 2002 Mar 8;438(3):137-42. Erratum in: Eur J Pharmacol. 2002 Aug 16;450(1):111.

PMID:
11909604
26.

Human organic anion transporters and human organic cation transporters mediate renal transport of prostaglandins.

Kimura H, Takeda M, Narikawa S, Enomoto A, Ichida K, Endou H.

J Pharmacol Exp Ther. 2002 Apr;301(1):293-8.

PMID:
11907186
27.

Human organic anion transporters and human organic cation transporters mediate renal antiviral transport.

Takeda M, Khamdang S, Narikawa S, Kimura H, Kobayashi Y, Yamamoto T, Cha SH, Sekine T, Endou H.

J Pharmacol Exp Ther. 2002 Mar;300(3):918-24.

PMID:
11861798
28.

Human organic anion transporters mediate the transport of tetracycline.

Babu E, Takeda M, Narikawa S, Kobayashi Y, Yamamoto T, Cha SH, Sekine T, Sakthisekaran D, Endou H.

Jpn J Pharmacol. 2002 Jan;88(1):69-76.

29.

Characterization of ochratoxin A transport by human organic anion transporters.

Jung KY, Takeda M, Kim DK, Tojo A, Narikawa S, Yoo BS, Hosoyamada M, Cha SH, Sekine T, Endou H.

Life Sci. 2001 Sep 21;69(18):2123-35.

PMID:
11669456
30.

Characterization of organic anion transport inhibitors using cells stably expressing human organic anion transporters.

Takeda M, Narikawa S, Hosoyamada M, Cha SH, Sekine T, Endou H.

Eur J Pharmacol. 2001 May 11;419(2-3):113-20. Erratum in: Eur J Pharmacol 2002 Apr 26;441(3):215.

PMID:
11426832
31.

Comparison of the nucleic acids of helical and coccoid forms of Helicobacter pylori.

Narikawa S, Kawai S, Aoshima H, Kawamata O, Kawaguchi R, Hikiji K, Kato M, Iino S, Mizushima Y.

Clin Diagn Lab Immunol. 1997 May;4(3):285-90.

32.

Streptococcus oralis previously identified as uncommon 'Streptococcus sanguis' in Behçet's disease.

Narikawa S, Suzuki Y, Takahashi M, Furukawa A, Sakane T, Mizushima Y.

Arch Oral Biol. 1995 Aug;40(8):685-90.

PMID:
7487566
33.

Oxygen and carbon dioxide requirements of Helicobacter pylori.

Narikawa S, Imai N, Yamamoto M, Suzuki T, Yanagawa A, Mizushima Y.

Acta Microbiol Immunol Hung. 1995;42(4):367-71.

PMID:
8689088
34.

Lactate dehydrogenase activity as a cause of metronidazole resistance in Bacteroides fragilis NCTC 11295.

Narikawa S, Suzuki T, Yamamoto M, Nakamura M.

J Antimicrob Chemother. 1991 Jul;28(1):47-53.

PMID:
1769942
35.

[Evaluation of agar media for growth of Campylobacter pylori].

Narikawa S, Imai N, Sakama S, Harasawa I, Suzuki T, Nakamura M.

Rinsho Byori. 1990 Jan;38(1):104-6. Japanese.

PMID:
2308216
36.

[Rapid diagnosis of gram-negative bacteriuria with endotoxin-specific chromogenic test].

Aoyama E, Yamamoto M, Tamura H, Tanaka S, Narikawa S, Nozawa F, Obayashi T, Kawai T, Nakamura M.

Rinsho Byori. 1989 Nov;37(11):1274-8. Japanese.

PMID:
2601086
37.

Differentiation of obligate anaerobes by assay of pyruvate:ferredoxin oxidoreductase activity.

Narikawa S, Nakamura M.

Eur J Clin Microbiol. 1987 Feb;6(1):74-5.

PMID:
3552667
38.

Distribution of metronidazole susceptibility factors in obligate anaerobes.

Narikawa S.

J Antimicrob Chemother. 1986 Nov;18(5):565-74.

PMID:
3804881
39.

[Metronidazole-inactivating activity of cell-free extracts of Streptococcus faecalis].

Narikawa S, Harasawa I, Nakamura M.

Nihon Saikingaku Zasshi. 1985 Mar;40(2):501-9. Japanese. No abstract available.

PMID:
3928941
40.

Staphylococcal capsular vaccine for preventing mastitis in two herds in Georgia.

Yoshida K, Ichiman Y, Narikawa S, Evans WB.

J Dairy Sci. 1984 Mar;67(3):620-7.

41.

[Metronidazole strip method for differentiating single colonies of obligate from facultative anaerobes on primary agar plates].

Narikawa S, Nakashio S, Nishida S, Nakamura M, Harasawa I.

Kansenshogaku Zasshi. 1983 Jun;57(6):459-69. Japanese. No abstract available.

PMID:
6443732
42.

Growth of Staphylococcus epidermidis in soft agar in relation to respiration, dehydrogenase activity and biotype.

Ohtomo T, Ichiman Y, Narikawa S, Yoshida K.

J Gen Microbiol. 1982 Sep;128(9):2141-7.

PMID:
7175497
43.
44.

[Difference in oxygen requirements between the metronidazole-sensitive parent strain and its resistant variant of Campylobacter jejuni].

Narikawa S, Nakashio S, Koinuma I, Harasawa I, Nakamura M, Yoshizaki E, Kamiki T.

Nihon Saikingaku Zasshi. 1982 May;37(3):619-21. Japanese. No abstract available.

PMID:
7131777
45.
46.

Synergistic effect of rabbit specific antiserum and amikacin on the treatment of mice with lethal infection due to Klebsiella pneumoniae.

Yoshida K, Takahashi M, Narikawa S.

Experientia. 1981;37(9):956-7. No abstract available.

PMID:
7028503
47.

[Isolation of a serologically heterologous compact-colony-forming active substance from a strain of Staphylococcus epidermidis (author's transl)].

Usui Y, Narikawa S, Ichiman Y, Yoshida K.

Nihon Saikingaku Zasshi. 1979 Nov;34(6):847-51. Japanese. No abstract available.

PMID:
316831
48.

Relation of colonial morphologies of strain of Streptococcus pneumoniae in soft-agar to the encapsulation.

Yoshida K, Takahashi M, Ichiman Y, Narikawa S, Kono E.

Asian J Infect Dis. 1979 Sep;3(3):125-8.

PMID:
45301
49.

Passive protection by human serum in mice infected with encapsulated Staphylococcus aureus.

Yoshida K, Ichiman Y, Narikawa S, Takahashi M, Kono E, San Clemente CL.

J Med Microbiol. 1979 Aug;12(3):277-82.

PMID:
469929
50.

[Effect of combination of hetacillin, cephapirin and amikacin (author's transl)].

Takahashi M, Ichiman Y, Usui Y, Narikawa S, Yoshida K.

Jpn J Antibiot. 1979 Aug;32(8):830-8. Japanese.

PMID:
114683

Supplemental Content

Loading ...
Support Center